Alberto Buson

Title: The Innovations of Alberto Buson

Introduction

Alberto Buson is a notable inventor based in Macquarie Park, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target neuromuscular and neuroinflammatory diseases.

Latest Patents

Buson holds a patent for "Haloallylamine dual amine oxidase inhibitors." This invention relates to novel compounds capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are particularly useful for treating various neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases affecting both peripheral and central systems in humans, pets, and livestock. The patent also encompasses pharmaceutical compositions containing these compounds and their various applications.

Career Highlights

Alberto Buson is associated with Syntara Limited, where he continues to innovate and develop new therapeutic solutions. His work has the potential to impact the treatment of several debilitating conditions, showcasing his commitment to advancing medical science.

Collaborations

Buson has collaborated with notable colleagues, including Alan Duncan Robertson and Alison Dorothy Findlay. These partnerships have likely contributed to the success and development of his innovative projects.

Conclusion

Alberto Buson exemplifies the spirit of innovation in the pharmaceutical industry, with his patent addressing critical health issues. His work continues to pave the way for advancements in treatment options for various diseases.